Low risk episodes of fever and neutropenia in pediatric oncology: Is outpatient oral antibiotic therapy the new gold standard of care?

被引：20

作者：

Ammann, RA ^{[1
]}

Simon, A

de Bont, ESJM

机构：

[1] Univ Bern, Childrens Hosp, Inselspital, CH-3010 Bern, Switzerland

[2] Univ Bonn, Dept Pediat Hematol & Oncol, D-5300 Bonn, Germany

[3] Beatrix Children Hosp, Childrens Canc Ctr, Div Pediat Oncol, Groningen, Netherlands

来源：

PEDIATRIC BLOOD & CANCER | 2005年 / 45卷 / 03期

关键词：

cancer; children; fever; neutropenia; infections; supportive care;

D O I：

10.1002/pbc.20287

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：244 / 247

页数：4

共 24 条

[1]

Alexander SW, 2002, PRINCIPLES PRACTICE, P1239

[2]

Ammann RA, 2004, CANCER-AM CANCER SOC, V100, P1547, DOI 10.1002/cncr.20118

[3] Predicting bacteremia in children with fever and chemotherapy-induced neutropenia [J].

Ammann, RA ;

Hirt, A ;

Lüthy, AR ;

Aebi, C .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (01) :61-67

[4]

Aquino VM, 2000, CANCER, V88, P1710, DOI 10.1002/(SICI)1097-0142(20000401)88:7<1710::AID-CNCR27>3.3.CO

[5]

2-T

[6]

Baorto EP, 2001, CANCER, V92, P909, DOI 10.1002/1097-0142(20010815)92:4<909::AID-CNCR1400>3.0.CO

[7]

2-H

[8] Methodology for clinical trials involving patients with cancer who have febrile neutropenia: Updated guidelines of the Immunocompromised Host Society/Multinational Association for Supportive Care in Cancer, with emphasis on outpatient studies [J].

Feld, R ;

Paesmans, M ;

Freifeld, AG ;

Klastersky, J ;

Pizzo, PA ;

Rolston, KVI ;

Rubenstein, E ;

Talcott, JA ;

Walsh, TJ .

CLINICAL INFECTIOUS DISEASES, 2002, 35 (12) :1463-1468

[9] A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy [J].

Freifeld, A ;

Marchigiani, D ;

Walsh, T ;

Chanock, S ;

Lewis, L ;

Hiemenz, J ;

Hiemenz, S ;

Hicks, JE ;

Gill, V ;

Steinberg, SM ;

Pizzo, PP .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (05) :305-311

[10]

Holdsworth Mark, 2003, Paediatr Drugs, V5, P443, DOI 10.2165/00148581-200305070-00002

← 1 2 3 →